Literature DB >> 3661794

Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.

M C Weinstein1, P G Coxson, L W Williams, T M Pass, W B Stason, L Goldman.   

Abstract

A computer simulation model was developed to project the future mortality, morbidity, and cost of coronary heart disease (CHD) in the United States population. The model contains a demographic-epidemiologic (DE) submodel, which stimulates the distribution of coronary risk factors and the conditional incidence of CHD in a demographically evolving population; a "bridge" submodel, which determines the outcome of the initial CHD event; and a disease history (DH) submodel, which simulates subsequent events in persons with a previous CHD event. The user of the model may simulate the effects of interventions, either preventive (i.e., risk factor modification) or therapeutic, upon mortality, morbidity, and cost for up to a 30-year period. If there were no future changes in risk factors or the efficacy of therapies after 1980, baseline projections indicate that the aging of the population, and especially the maturation of the post-World War II baby-boom generation, would increase CHD prevalence and annual incidence, mortality, and costs by about 40-50 per cent by the year 2010. Unprecedented reductions in risk factors would be required to offset these demographic effects on the absolute incidence of CHD. The specific forecasts could be inaccurate, however, as a consequence of erroneous assumptions or misestimated baseline data, and the model awaits validation based on actual future data.

Entities:  

Mesh:

Year:  1987        PMID: 3661794      PMCID: PMC1647098          DOI: 10.2105/ajph.77.11.1417

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  29 in total

1.  Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation.

Authors:  W A Schaffer; L A Cobb
Journal:  N Engl J Med       Date:  1975-08-07       Impact factor: 91.245

2.  Survival after resuscitation from out-of-hospital ventricular fibrillation.

Authors:  R S Baum; H Alvarez; L A Cobb
Journal:  Circulation       Date:  1974-12       Impact factor: 29.690

3.  Coronary prognostic index for predicting survival after recovery from acute myocardial infarction.

Authors:  R M Norris; D E Caughey; L W Deeming; C J Mercer; P J Scott
Journal:  Lancet       Date:  1970-09-05       Impact factor: 79.321

4.  Natural history of angina pectoris in the Framingham study. Prognosis and survival.

Authors:  W B Kannel; M Feinleib
Journal:  Am J Cardiol       Date:  1972-02       Impact factor: 2.778

5.  Prevention and rehabilitation as a means of cost containment: the example of myocardial infarction.

Authors:  W H Luginbuhl; B R Forsyth; G B Hirsch; M R Goodman
Journal:  J Public Health Policy       Date:  1981-06       Impact factor: 2.222

6.  Paramedic programs and out-of-hospital cardiac arrest: I. Factors associated with successful resuscitation.

Authors:  M Eisenberg; L Bergner; A Hallstrom
Journal:  Am J Public Health       Date:  1979-01       Impact factor: 9.308

7.  The course of patients with suspected myocardial infarction. The identification of low-risk patients for early transfer from intensive care.

Authors:  A G Mulley; G E Thibault; R A Hughes; G O Barnett; V A Reder; E L Sherman
Journal:  N Engl J Med       Date:  1980-04-24       Impact factor: 91.245

8.  Survivorship patterns in the posthospital phase of myocardial infarction.

Authors:  H T Davis; J DeCamilla; L W Bayer; A J Moss
Journal:  Circulation       Date:  1979-12       Impact factor: 29.690

9.  Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS).

Authors:  J W Kennedy; G C Kaiser; L D Fisher; J K Fritz; W Myers; J G Mudd; T J Ryan
Journal:  Circulation       Date:  1981-04       Impact factor: 29.690

10.  Characteristics of the resuscitated out-of-hospital cardiac arrest victim with coronary heart disease.

Authors:  S Goldstein; J R Landis; R Leighton; G Ritter; C M Vasu; A Lantis; R Serokman
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

View more
  91 in total

1.  How good is the Prevent model for estimating the health benefits of prevention?

Authors:  H Brønnum-Hansen
Journal:  J Epidemiol Community Health       Date:  1999-05       Impact factor: 3.710

Review 2.  Real world designs in economic evaluation. Bridging the gap between clinical research and policy-making.

Authors:  R Baltussen; R Leidl; A Ament
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

Review 3.  Cost per millimeter of mercury lowering is a measure of economic value for antihypertensive agents.

Authors:  R S Chen; P Lapuerta
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

4.  Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis.

Authors:  Benjamin Z Galper; Andrew Moran; Pamela G Coxson; Mark J Pletcher; Paul Heidenreich; Lawrence D Lazar; Nicolas Rodondi; Y Claire Wang; Lee Goldman
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

Review 5.  Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.

Authors:  Brahmajee K Nallamothu; A Mark Fendrick; Gilbert S Omenn
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

6.  Long-term impact of smoking cessation on the incidence of coronary heart disease.

Authors:  A N Tosteson; M C Weinstein; L W Williams; L Goldman
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

Review 7.  Practical experiences in auditing patient outcomes.

Authors:  M J Bardsley; J M Coles
Journal:  Qual Health Care       Date:  1992-06

8.  Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway.

Authors:  John R Cook; Don Yin; Evo Alemao; Glenn Davies; Karl J Krobot; Enrico Veltri; Leslie Lipka; Xavier Badia
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 9.  A review of health care models for coronary heart disease interventions.

Authors:  K Cooper; S C Brailsford; R Davies; J Raftery
Journal:  Health Care Manag Sci       Date:  2006-11

10.  Impact on cardiovascular disease events of the implementation of Argentina's national tobacco control law.

Authors:  Jonatan Konfino; Daniel Ferrante; Raul Mejia; Pamela Coxson; Andrew Moran; Lee Goldman; Eliseo J Pérez-Stable
Journal:  Tob Control       Date:  2012-10-23       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.